Brigatinib in patients with ALK-positive advanced non-small cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)

Affiliation auteurs!!!! Error affiliation !!!!
TitreBrigatinib in patients with ALK-positive advanced non-small cell lung cancer pretreated with sequential ALK inhibitors: A multicentric real-world study (BRIGALK study)
Type de publicationJournal Article
Year of Publication2020
AuteursDescourt R., Perol M., Planchard D., Rousseau-Bussac G., Mennecier B., Wislez M., Cadranel J., Cortot A.B, Guisier F., Do P., Schott R., Dansin E., Arrondeau J., Auliac J.B, Chouaid C., Galland L.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS884
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.1706